Modulation of endothelial glycocalyx structure under inflammatory conditions

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Kolářová, Hana ^a,b   Ambrůzová, Barbora ^a,c   Švihálková Šindlerová, Lenka ^a,b   Klinke, Anna ^d   Kubala, Lukáš ^a,b  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c MASARYK UNIVERSITY   (Czech Republic)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GLYCOCALYX; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; GLYCOCALYX; HUMANS; INFLAMMATION;

EID: 84899416510     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/694312     Document Type: Review

References (151)

1. Gouverneur M., van den Berg B., Nieuwdorp M., Stroes E., Vink H., Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. Journal of Internal Medicine 2006 259 4 393 400 2-s2.0-33644898803 10.1111/j.1365-2796.2006.01625.x (Pubitemid 43384230)
2. Reitsma S., Slaaf D. W., Vink H., van Zandvoort M. A. M. J., Oude Egbrink M. G. A., The endothelial glycocalyx: composition, functions, and visualization. Pflugers Archiv European Journal of Physiology 2007 454 3 345 359 2-s2.0-34248377676 10.1007/s00424-007-0212-8 (Pubitemid 46742429)
3. Tarbell J. M., Weinbaum S., Kamm R. D., Cellular fluid mechanics and mechanotransduction. Annals of Biomedical Engineering 2005 33 12 1719 1723 2-s2.0-29844432467 10.1007/s10439-005-8775-z (Pubitemid 43037541)
4. VanTeeffelen J. W., Brands J., Stroes E. S., Vink H., Endothelial glycocalyx: sweet shield of blood vessels. Trends in Cardiovascular Medicine 2007 17 3 101 105 2-s2.0-34047198585 10.1016/j.tcm.2007.02.002 (Pubitemid 46533936)
5. Becker B. F., Chappell D., Bruegger D., Annecke T., Jacob M., Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovascular Research 2010 87 2 300 310 2-s2.0-77954325542 10.1093/cvr/cvq137
6. Becker B. F., Chappell D., Jacob M., Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Research in Cardiology 2010 105 6 687 701 2-s2.0-78649327676 10.1007/s00395-010-0118-z
7. Pries A. R., Secomb T. W., Gaehtgens P., The endothelial surface layer. Pflugers Archiv European Journal of Physiology 2000 440 5 653 666 2-s2.0-0033821746
8. van den Berg B., Vink H., Glycocalyx perturbation: cause or consequence of damage to the vasculature? American Journal of Physiology: Heart and Circulatory Physiology 2006 290 6 H2174 H2175 2-s2.0-33744937890 10.1152/ajpheart.00197.2006 (Pubitemid 43846041)
9. van den Berg B. M., Nieuwdorp M., Stroes E. S. G., Vink H., Glycocalyx and endothelial (dys) function: from mice to men. Pharmacological Reports 2006 58 75 80 2-s2.0-34447253418
10. Curry F. E., Adamson R. H., Endothelial glycocalyx: permeability barrier and mechanosensor. Annals of Biomedical Engineering 2012 40 828 839 2-s2.0-80054080521 10.1007/s10439-011-0429-8
11. Tarbell J. M., Pahakis M. Y., Mechanotransduction and the glycocalyx. Journal of Internal Medicine 2006 259 4 339 350 2-s2.0-33644931089 10.1111/j.1365-2796.2006.01620.x (Pubitemid 43384225)
12. Alexopoulou A. N., Multhaupt H. A. B., Couchman J. R., Syndecans in wound healing, inflammation and vascular biology. International Journal of Biochemistry and Cell Biology 2007 39 3 505 528 2-s2.0-33846246406 10.1016/j.biocel.2006.10.014 (Pubitemid 46099032)
13. Fears C. Y., Woods A., The role of syndecans in disease and wound healing. Matrix Biology 2006 25 7 443 456 2-s2.0-33749441307 10.1016/j.matbio.2006.07.003 (Pubitemid 44512121)
14. Tkachenko E., Rhodes J. M., Simons M., Syndecans: new kids on the signaling block. Circulation Research 2005 96 5 488 500 2-s2.0-16244380777 10.1161/01.RES.0000159708.71142.c8 (Pubitemid 40463457)
15. De Cat B., David G., Developmental roles of the glypicans. Seminars in Cell and Developmental Biology 2001 12 2 117 125 2-s2.0-0035783047 10.1006/scdb.2000.0240
16. Maksimenko A. V., Turashev A. D., No-reflow phenomenon and endothelial glycocalyx of microcirculation. Biochemistry Research International 2012 2012 10 2-s2.0-84855605264 10.1155/2012/859231 859231
17. Moreth K., Iozzo R. V., Schaefer L., Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation. Cell Cycle 2012 11 2084 2091
18. Chen S., Birk D. E., The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS Journal 2013 280 2120 2137
19. Nastase M. V., Young M. F., Schaefer L., Biglycan: a multivalent proteoglycan providing structure and signals. Journal of Histochemistry & Cytochemistry 2012 60 963 975
20. Gandhi N. S., Mancera R. L., The structure of glycosaminoglycans and their interactions with proteins. Chemical Biology and Drug Design 2008 72 6 455 482 2-s2.0-56649100319 10.1111/j.1747-0285.2008.00741.x
21. Götte M., Syndecans in inflammation. The FASEB Journal 2003 17 6 575 591 2-s2.0-0037387945 10.1096/fj.02-0739rev (Pubitemid 37221142)
22. Xian X., Gopal S., Couchman J. R., Syndecans as receptors and organizers of the extracellular matrix. Cell and Tissue Research 2010 339 1 31 46 2-s2.0-72449210453 10.1007/s00441-009-0829-3
23. Mikami T., Kitagawa H., Biosynthesis and function of chondroitin sulfate. Biochimica et Biophysica Acta 2013 1830 4719 4733
24. Kwok J. C. F., Warren P., Fawcett J. W., Chondroitin sulfate: a key molecule in the brain matrix. International Journal of Biochemistry and Cell Biology 2012 44 4 582 586 2-s2.0-84857913115 10.1016/j.biocel.2012.01.004
25. Lennon F. E., Singleton P. A., Hyaluronan regulation of vascular integrity. American Journal of Cardiovascular Disease 2011 1 200 213
26. Takagi J., Structural basis for ligand recognition by integrins. Current Opinion in Cell Biology 2007 19 5 557 564 2-s2.0-35548939067 10.1016/j.ceb.2007.09.002 (Pubitemid 350016853)
27. Ehrhardt C., Kneuer C., Bakowsky U., Selectins-an emerging target for drug delivery. Advanced Drug Delivery Reviews 2004 56 4 527 549 2-s2.0-1142273197 10.1016/j.addr.2003.10.029 (Pubitemid 38210421)
28. Jubeli E., Moine L., Vergnaud-Gauduchon J., Barratt G., E-selectin as a target for drug delivery and molecular imaging. Journal of Controlled Release 2012 158 2 194 206 2-s2.0-84858703130 10.1016/j.jconrel.2011.09.084
29. Luo B.-H., Springer T. A., Integrin structures and conformational signaling. Current Opinion in Cell Biology 2006 18 5 579 586 2-s2.0-33748306120 10.1016/j.ceb.2006.08.005 (Pubitemid 44332909)
30. Nieuwdorp M., Meuwese M. C., Vink H., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G., The endothelial glycocalyx: a potential barrier between health and vascular disease. Current Opinion in Lipidology 2005 16 5 507 511 2-s2.0-25444507965 (Pubitemid 41376899)
31. Ebong E. E., MacAluso F. P., Spray D. C., Tarbell J. M., Imaging the endothelial glycocalyx in vitro by rapid freezing/freeze substitution transmission electron microscopy. Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 8 1908 1915 2-s2.0-80051551690 10.1161/ATVBAHA.111.225268
32. Luft J. H., Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Federation Proceedings 1966 25 6 1773 1783 2-s2.0-0013965183
33. Janczyk P., Hansen S., Bahramsoltani M., Plendl J., The glycocalyx of human, bovine and murine microvascular endothelial cells cultured in vitro. Journal of Electron Microscopy 2010 59 4 291 298 2-s2.0-77955537291 10.1093/jmicro/dfq007
34. Ueda A., Shimomura M., Ikeda M., Yamaguchi R., Tanishita K., Effect of glycocalyx on shear-dependent albumin uptake in endothelial cells. American Journal of Physiology: Heart and Circulatory Physiology 2004 287 5 H2287 H2294 2-s2.0-7244256096 10.1152/ajpheart.00808.2003 (Pubitemid 39430768)
35. Devaraj S., Yun J.-M., Adamson G., Galvez J., Jialal I., C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction. Cardiovascular Research 2009 84 3 479 484 2-s2.0-70849095298 10.1093/cvr/cvp249
36. Chappell D., Jacob M., Paul O., Rehm M., Welsch U., Stoeckelhuber M., Conzen P., Becker B. F., The glycocalyx of the human umbilical vein endothelial cell: an impressive structure ex vivo but not in culture. Circulation Research 2009 104 11 1313 1317 2-s2.0-66449090699 10.1161/CIRCRESAHA.108.187831
37. Vogel J., Sperandio M., Pries A. R., Linderkamp O., Gaehtgens P., Kuschinsky W., Influence of the endothelial glycocalyx on cerebral blood flow in mice. Journal of Cerebral Blood Flow and Metabolism 2000 20 11 1571 1578 2-s2.0-0033762165
38. Singh A., Satchell S. C., Neal C. R., McKenzie E. A., Tooke J. E., Mathieson P. W., Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. Journal of the American Society of Nephrology 2007 18 11 2885 2893 2-s2.0-35848940725 10.1681/ASN.2007010119 (Pubitemid 350058395)
39. van den Berg B. M., Vink H., Spaan J. A. E., The endothelial glycocalyx protects against myocardial edema. Circulation Research 2003 92 6 592 594 2-s2.0-0037418913 10.1161/01.RES.0000065917.53950.75 (Pubitemid 36417691)
40. van den Berg B. M., Spaan J. A. E., Vink H., Impaired glycocalyx barrier properties contribute to enhanced intimal low-density lipoprotein accumulation at the carotid artery bifurcation in mice. Pflugers Archiv European Journal of Physiology 2009 457 6 1199 1206 2-s2.0-62549085175 10.1007/s00424-008-0590-6
41. Rostgaard J., Qvortrup K., Poulsen S. S., Improvements in the technique of vascular perfusion-fixation employing a fluorocarbon-containing perfusate and a peristaltic pump controlled by pressure feedback. Journal of Microscopy 1993 172 2 137 151 2-s2.0-0027365644 (Pubitemid 23354931)
42. Sims D. E., Horne M. M., Non-aqueous fixative preserves macromolecules on the endothelial cell surface: an in situ study. European Journal of Morphology 1993 31 4 251 256 2-s2.0-0027880186 (Pubitemid 24082856)
43. Reitsma S., Oude Egbrink M. G. A., Vink H., van den Berg B. M., Lima Passos V., Engels W., Slaaf D. W., van Zandvoort M. A. M. J., Endothelial glycocalyx structure in the intact carotid artery: a two-photon laser scanning microscopy study. Journal of Vascular Research 2011 48 4 297 306 2-s2.0-79151480759 10.1159/000322176
44. de Mesy Bentley K. L., An 11-mum-thick glycocalyx?: it's all in the technique! Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 1712 1713
45. Savery M. D., Jiang J. X., Park P. W., Damiano E. R., The endothelial glycocalyx in syndecan-1 deficient mice. Microvascular Research 2013 87 83 91
46. Vanteeffelen J. W. G. E., Brands J., Vink H., Agonist-induced impairment of glycocalyx exclusion properties: contribution to coronary effects of adenosine. Cardiovascular Research 2010 87 2 311 319 2-s2.0-77954321270 10.1093/cvr/cvq114
47. Vink H., Duling B. R., Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circulation Research 1996 79 3 581 589 2-s2.0-0029797605 (Pubitemid 26276918)
48. Vink H., Duling B. R., Capillary endothelial surface layer selectively reduces plasma solute distribution volume. American Journal of Physiology: Heart and Circulatory Physiology 2000 278 1 H285 H289 2-s2.0-0033976142 (Pubitemid 30101882)
49. Henry C. B. S., Duling B. R., Permeation of the luminal capillary glycocalyx is determined by hyaluronan. American Journal of Physiology: Heart and Circulatory Physiology 1999 277 2 H508 H514 2-s2.0-0032872697 (Pubitemid 29415963)
50. Gao L., Lipowsky Herbert H. H. H., Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes. Microvascular Research 2010 80 3 394 401 2-s2.0-78249282251 10.1016/j.mvr.2010. 06.005
51. Yen W.-Y., Cai B., Zeng M., Tarbell J. M., Fu B. M., Quantification of the endothelial surface glycocalyx on rat and mouse blood vessels. Microvascular Research 2012 83 3 337 346 2-s2.0-84859508552 10.1016/j.mvr.2012.02.005
52. Torres Filho I., Torres L. N., Sondeen J. L., Polykratis I. A., Dubick M. A., In vivo evaluation of venular glycocalyx during hemorrhagic shock in rats using intravital microscopy. Microvascular Research 2013 85 128 133 10.1016/j.mvr.2012.11.005
53. Potter D. R., Damiano E. R., The hydrodynamically relevant endothelial cell glycocalyx observed in vivo is absent in vitro. Circulation Research 2008 102 7 770 776 2-s2.0-42049083793 10.1161/CIRCRESAHA.107.160226 (Pubitemid 351521584)
54. Smith M. L., Long D. S., Damiano E. R., Ley K., Near-wall -PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophysical Journal 2003 85 1 637 645 2-s2.0-0038311020 (Pubitemid 36753665)
55. den Uil C. A., Klijn E., Lagrand W. K., Brugts J. J., Ince C., Spronk P. E., Simoons M. L., The microcirculation in health and critical disease. Progress in Cardiovascular Diseases 2008 51 2 161 170 2-s2.0-50849095839 10.1016/j.pcad.2008.07.002
56. Nieuwdorp M., Meuwese M. C., Mooij H. L., Ince C., Broekhuizen L. N., Kastelein J. J. P., Stroes E. S. G., Vink H., Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability. Journal of Applied Physiology 2008 104 3 845 852 2-s2.0-41549164701 10.1152/japplphysiol.00440.2007 (Pubitemid 351468815)
57. Nieuwdorp M., Meuwese M. C., Mooij H. L., van Lieshout M. H. P., Hayden A., Levi M., Meijers J. C. M., Ince C., Kastelein J. J. P., Vink H., Stroes E. S. G., Tumor necrosis factor-inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis 2009 202 1 296 303 2-s2.0-57649155207 10.1016/j.atherosclerosis.2008.03.024
58. Vlahu C. A., Lemkes B. A., Struijk D. G., Damage of the endothelial glycocalyx in dialysis patients. Journal of the American Society of Nephrology 2012 23 1900 1908
59. Barker K. N., Flynn E. A., Pepper G. A., Observation method of detecting medication errors. American Journal of Health-System Pharmacy 2002 59 23 2314 2316 2-s2.0-0036994812 (Pubitemid 36221886)
60. Megens R. T. A., Oude Egbrink M. G. A., Merkx M., Slaaf D. W., van Zandvoort M. A. M. J., Two-photon microscopy on vital carotid arteries: imaging the relationship between collagen and inflammatory cells in atherosclerotic plaques. Journal of Biomedical Optics 2008 13 4 2-s2.0-58149401290 10.1117/1.2965542 044022
61. Megens R. T. A., Reitsma S., Prinzen L., Oude Egbrink M. G. A., Engels W., Leenders P. J. A., Brunenberg E. J. L., Reesink K. D., Janssen B. J. A., Ter Haar Romeny B. M., Slaaf D. W., van Zandvoort M. A. M. J., In vivo high-resolution structural imaging of large arteries in small rodents using two-photon laser scanning microscopy. Journal of Biomedical Optics 2010 15 1 2-s2.0-77953164441 10.1117/1.3281672 011108
62. Bai K., Wang W., Spatio-temporal development of the endothelial glycocalyx layer and its mechanical property in vitro. Journal of the Royal Society Interface 2012 9 74 2290 2298 10.1098/rsif.2011.0901
63. Potter D. R., Jiang J., Damiano E. R., The recovery time course of the endothelial cell glycocalyx in vivo and its implications in vitro. Circulation Research 2009 104 11 1318 1325 2-s2.0-67649871387 10.1161/CIRCRESAHA.108.191585
64. Bai K., Wang W., Shear stress-induced redistribution of the glycocalyx on endothelial cells in vitro. Biomechanics and Modeling in Mechanobiology 2013 10.1007/s10237-013-0502-3
65. Yao Y., Rabodzey A., Dewey C. F. Jr., Glycocalyx modulates the motility and proliferative response of vascular endothelium to fluid shear stress. American Journal of Physiology: Heart and Circulatory Physiology 2007 293 2 H1023 H1030 2-s2.0-34547899189 10.1152/ajpheart.00162.2007 (Pubitemid 47254201)
66. Rosenberg R. D., Shworak N. W., Liu J., Schwartz J. J., Zhang L., Heparan sulfate proteoglycans of the cardiovascular system: specific structures emerge but how is synthesis regulated? Journal of Clinical Investigation 1997 100 11 S67 S75 2-s2.0-0031442530 (Pubitemid 28009550)
67. Chappell D., Hofmann-Kiefer K., Jacob M., Rehm M., Briegel J., Welsch U., Conzen P., Becker B. F., TNF- induced shedding of the endothelial glycocalyx is prevented by hydrocortisone and antithrombin. Basic Research in Cardiology 2009 104 1 78 89 2-s2.0-57949090715 10.1007/s00395-008-0749-5
68. Chappell D., Jacob M., Hofmann-Kiefer K., Rehm M., Welsch U., Conzen P., Becker B. F., Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovascular Research 2009 83 2 388 396 2-s2.0-67650260648 10.1093/cvr/cvp097
69. Henrich M., Gruss M., Weigand M. A., Sepsis-induced degradation of endothelial glycocalix. TheScientificWorldJournal 2010 10 917 923 2-s2.0-77953425061 10.1100/tsw.2010.88
70. van Golen R. F., van Gulik T. M., Heger M., Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury. Free Radical Biology and Medicine 2012 52 8 1382 1402 2-s2.0-84859008844 10.1016/j.freeradbiomed.2012.01.013
71. Nieuwdorp M., Mooij H. L., Kroon J., Atasever B., Spaan J. A. E., Ince C., Holleman F., Diamant M., Heine R. J., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G., Vink H., Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. Diabetes 2006 55 4 1127 1132 2-s2.0-33745311155 10.2337/diabetes.55.04.06.db05-1619 (Pubitemid 44100191)
72. Nieuwdorp M., van Haeften T. W., Gouverneur M. C. L. G., Mooij H. L., van Lieshout M. H. P., Levi M., Meijers J. C. M., Holleman F., Hoekstra J. B. L., Vink H., Kastelein J. J. P., Stroes E. S. G., Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. Diabetes 2006 55 2 480 486 2-s2.0-33644759419 10.2337/diabetes.55.02.06.db05-1103 (Pubitemid 43343279)
73. Rehm M., Haller M., Orth V., Kreimeier U., Jacob M., Dressel H., Mayer S., Brechtelsbauer H., Finsterer U., Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001 95 4 849 856 2-s2.0-0034785698 (Pubitemid 32939106)
74. Perrin R. M., Harper S. J., Bates D. O., A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus. Cell Biochemistry and Biophysics 2007 49 2 65 72 2-s2.0-35348838942 10.1007/s12013-007-0041-6 (Pubitemid 47574998)
75. Mulivor A. W., Lipowsky H. H., Role of glycocalyx in leukocyte- endothelial cell adhesion. American Journal of Physiology: Heart and Circulatory Physiology 2002 283 4 H1282 H1291 2-s2.0-0036783567
76. Lipowsky H. H., The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Annals of Biomedical Engineering 2012 40 840 848 2-s2.0-80053511563 10.1007/s10439-011-0427-x
77. Constantinescu A. A., Vink H., Spaan J. A. E., Endothelial cell glycocalyx modulates immobilization of leukocytes at the endothelial surface. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 9 1541 1547 2-s2.0-0042190645 10.1161/01.ATV.0000085630.24353.3D (Pubitemid 37108195)
78. Drake-Holland A. J., Noble M. I., Update on the important new drug target in cardiovascular medicine-the vascular glycocalyx. Cardiovascular & Hematological Disorders-Drug Targets 2012 12 1 76 81 10.2174/187152912801823183
79. Broekhuizen L. N., Mooij H. L., Kastelein J. J. P., Stroes E. S. G., Vink H., Nieuwdorp M., Endothelial glycocalyx as potential diagnostic and therapeutic target in cardiovascular disease. Current Opinion in Lipidology 2009 20 1 57 62 2-s2.0-58849122773 10.1097/MOL.0b013e328321b587
80. Chappell D., Westphal M., Jacob M., The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Current Opinion in Anaesthesiology 2009 22 2 155 162 2-s2.0-68049108421 10.1097/ACO. 0b013e328328d1b6
81. Henry C. B. S., Duling B. R., TNF- increases entry of macromolecules into luminal endothelial cell glycocalyx. American Journal of Physiology: Heart and Circulatory Physiology 2000 279 6 H2815 H2823 2-s2.0-0034533811 (Pubitemid 32005870)
82. Pejler G., Åbrink M., Ringvall M., Wernersson S., Mast Cell Proteases. Advances in Immunology 2007 95 167 255 2-s2.0-34548504097 10.1016/S0065-2776(07)95006-3 (Pubitemid 47380506)
83. Chappell D., Jacob M., Hofmann-Kiefer K., Bruegger D., Rehm M., Conzen P., Welsch U., Becker B. F., Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007 107 5 776 784 2-s2.0-37349021137 10.1097/01.anes.0000286984.39328.96 (Pubitemid 351325970)
84. Chappell D., Jacob M., Rehm M., Stoeckelhuber M., Welsch U., Conzen P., Becker B. F., Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biological Chemistry 2008 389 1 79 82 2-s2.0-37349079316 10.1515/BC.2008.005 (Pubitemid 350308195)
85. Singh A., Ramnath R. D., Foster R. R., Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx. PLoS ONE 2013 8 e55852
86. Lipowsky H. H., Protease activity and the role of the endothelial glycocalyx in inflammation. Drug Discovery Today: Disease Models 2011 8 1 57 62 2-s2.0-82455167858 10.1016/j.ddmod.2011.05.004
87. Lipowsky H. H., Lescanic A., The effect of doxycycline on shedding of the glycocalyx due to reactive oxygen species. Microvascular Research 2013 90 80 85
88. Mulivor A. W., Lipowsky H. H., Inhibition of glycan shedding and leukocyte-endothelial adhesion in postcapillary venules by suppression of matrixmetalloprotease activity with doxycycline. Microcirculation 2009 16 8 657 666 2-s2.0-70350660542 10.3109/10739680903133714
89. Yu W.-H., Woessner J. F. Jr., Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7). The Journal of Biological Chemistry 2000 275 6 4183 4191 2-s2.0-0034635483 10.1074/jbc.275.6.4183 (Pubitemid 30094653)
90. Endo K., Takino T., Miyamori H., Kinsen H., Yoshizaki T., Furukawa M., Sato H., Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration. The Journal of Biological Chemistry 2003 278 42 40764 40770 2-s2.0-0142103466 10.1074/jbc.M306736200 (Pubitemid 37280893)
91. Gronski T. J. Jr., Martin R. L., Kobayashi D. K., Walsh B. C., Holman M. C., Huber M., van Wart H. E., Shapiro S. D., Hydrolysis of a broad spectrum of extracellular matrix proteins by human macrophage elastase. The Journal of Biological Chemistry 1997 272 18 12189 12194 2-s2.0-1842416597 10.1074/jbc.272.18.12189 (Pubitemid 27202803)
92. Suenaga N., Mori H., Itoh Y., Seiki M., CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase. Oncogene 2005 24 5 859 868 2-s2.0-13444273084 10.1038/sj.onc.1208258 (Pubitemid 40216094)
93. Mulivor A. W., Lipowsky H. H., Inflammation- and ischemia-induced shedding of venular glycocalyx. American Journal of Physiology: Heart and Circulatory Physiology 2004 286 5 H1672 H1680 2-s2.0-1942437470 10.1152/ajpheart.00832.2003 (Pubitemid 38525453)
94. Constantinescu A. A., Vink H., Spaan J. A. E., Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL. American Journal of Physiology: Heart and Circulatory Physiology 2001 280 3 H1051 H1057 2-s2.0-0034975472
95. Vink H., Constantinescu A. A., Spaan J. A. E., Oxidized lipoproteins degrade the endothelial surface layer: implications for platelet-endothelial cell adhesion. Circulation 2000 101 13 1500 1502 2-s2.0-0034603747 (Pubitemid 30180883)
96. Colburn P., Kobayashi E., Buonassisi V., Depleted level of heparan sulfate proteoglycan in the extracellular matrix of endothelial cell cultures exposed to endotoxin. Journal of Cellular Physiology 1994 159 1 121 130 2-s2.0-0028106380 10.1002/jcp.1041590116 (Pubitemid 24234584)
97. Huxley V. H., Williams D. A., Role of a glycocalyx on coronary arteriole permeability to proteins: evidence from enzyme treatments. American Journal of Physiology: Heart and Circulatory Physiology 2000 278 4 H1177 H1185 2-s2.0-0034091055 (Pubitemid 30235494)
98. Jeansson M., Granqvist A. B., Nyström J. S., Haraldsson B., Functional and molecular alterations of the glomerular barrier in long-term diabetes in mice. Diabetologia 2006 49 9 2200 2209 2-s2.0-33746747093 10.1007/s00125-006-0319-z (Pubitemid 44168489)
99. Jeansson M., Haraldsson B., Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. American Journal of Physiology: Renal Physiology 2006 290 1 F111 F116 2-s2.0-33644806727 10.1152/ajprenal.00173.2005
100. Mochizuki S., Vink H., Hiramatsu O., Kajita T., Shigeto F., Spaan J. A. E., Kajiya F., Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release. American Journal of Physiology: Heart and Circulatory Physiology 2003 285 2 H722 H726 2-s2.0-0038638291 (Pubitemid 36885905)
101. VanTeeffelen J. W. G. E., Brands J., Jansen C., Spaan J. A. E., Vink H., Heparin impairs glycocalyx barrier properties and attenuates shear dependent vasodilation in mice. Hypertension 2007 50 1 261 267 2-s2.0-34250803338 10.1161/HYPERTENSIONAHA.107.089250 (Pubitemid 46986050)
102. Bernfield M., Götte M., Park P. W., Reizes O., Fitzgerald M. L., Lincecum J., Zako M., Functions of cell surface heparan sulfate proteoglycans. Annual Review of Biochemistry 1999 68 729 777 2-s2.0-0032851160 10.1146/annurev.biochem.68.1.729 (Pubitemid 29449208)
103. Termeer C. C., Hennies J., Voith U., Ahrens T., Weiss J. M., Prehm P., Simon J. C., Oligosaccharides of hyaluronan are potent activators of dendritic cells. Journal of Immunology 2000 165 4 1863 1870 2-s2.0-0034663808 (Pubitemid 30643136)
104. Nelson A., Berkestedt I., Schmidtchen A., Ljunggren L., Bodelsson M., Increased levels of glycosaminoglycans during septic shock: relation to mortality and the antibacterial actions of plasma. Shock 2008 30 6 623 627 2-s2.0-54849433850 10.1097/SHK.0b013e3181777da3
105. Onat D., Brillon D., Colombo P. C., Schmidt A. M., Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis. Current Diabetes Reports 2011 11 3 193 202 2-s2.0-79955911075 10.1007/s11892-011-0182-2
106. Salmon A. H., Satchell S. C., Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability. Journal of Pathology 2012 226 4 562 574 2-s2.0-84856708866 10.1002/path.3964
107. Yuan S. Y., Ustinova E. E., Wu M. H., Tinsley J. H., Xu W., Korompai F. L., Taulman A. C., Protein kinase C activation contributes to microvascular barrier dysfunction in the heart at early stages of diabetes. Circulation Research 2000 87 5 412 417 2-s2.0-0034283423
108. Zuurbier C. J., Demirci C., Koeman A., Vink H., Ince C., Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells. Journal of Applied Physiology 2005 99 4 1471 1476 2-s2.0-29544436180 10.1152/japplphysiol. 00436.2005 (Pubitemid 43014356)
109. Kelly R., Ruane-O'Hora T., Noble M. I. M., Drake-Holland A. J., Snow H. M., Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig. Journal of Physiology 2006 573 1 133 145 2-s2.0-33646364791 10.1113/jphysiol. 2006.106500 (Pubitemid 43670863)
110. Title L. M., Cummings P. M., Giddens K., Nassar B. A., Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. Journal of the American College of Cardiology 2000 36 7 2185 2191 2-s2.0-0033673223 10.1016/S0735-1097(00)00980-3
111. Deckert T., Kofoed-Enevoldsen A., Vidal P., Norgaard K., Andreasen H. B., Feldt-Rasmussen B., Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 1993 36 3 244 251 2-s2.0-0027461162 (Pubitemid 23067087)
112. Broekhuizen L. N., Lemkes B. A., Mooij H. L., Meuwese M. C., Verberne H., Holleman F., Schlingemann R. O., Nieuwdorp M., Stroes E. S. G., Vink H., Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus. Diabetologia 2010 53 12 2646 2655 2-s2.0-78649318718 10.1007/s00125-010-1910-x
113. Singh A., Fridén V., Dasgupta I., Foster R. R., Welsh G. I., Tooke J. E., Haraldsson B., Mathieson P. W., Satchell S. C., High glucose causes dysfunction of the human glomerular endothelial glycocalyx. American Journal of Physiology: Renal Physiology 2011 300 1 F40 F48 2-s2.0-78651323207 10.1152/ajprenal.00103.2010
114. Nieuwdorp M., Holleman F., De Groot E., Vink H., Gort J., Kontush A., Chapman M. J., Hutten B. A., Brouwer C. B., Hoekstra J. B. L., Kastelein J. J. P., Stroes E. S. G., Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis. Diabetologia 2007 50 6 1288 1293 2-s2.0-34247842825 10.1007/s00125-007-0666-4 (Pubitemid 46701566)
115. Adamson R. H., Zeng M., Adamson G. N., Lenz J. F., Curry F. E., PAF- and bradykinin-induced hyperpermeability of rat venules is independent of actin-myosin contraction. American Journal of Physiology: Heart and Circulatory Physiology 2003 285 1 H406 H417 2-s2.0-0038000596 (Pubitemid 36736456)
116. Satchell S. C., Tooke J. E., What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium? Diabetologia 2008 51 5 714 725 2-s2.0-41849137193 10.1007/s00125-008-0961-8
117. Nagy N., Freudenberger T., Melchior-Becker A., Röck K., Ter Braak M., Jastrow H., Kinzig M., Lucke S., Suvorava T., Kojda G., Weber A. A., Sörgel F., Levkau B., Ergün S., Fischer J. W., Inhibition of hyaluronan synthesis accelerates murine atherosclerosis: novel insights into the role of hyaluronan synthesis. Circulation 2010 122 22 2313 2322 2-s2.0-78650131185 10.1161/CIRCULATIONAHA.110.972653
118. van den Berg B. M., Spaan J. A. E., Rolf T. M., Vink H., Atherogenic region and diet diminish glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. American Journal of Physiology: Heart and Circulatory Physiology 2006 290 2 H915 H920 2-s2.0-33644872553 10.1152/ajpheart.00051.2005
119. van Haaren P. M. A., VanBavel E., Vink H., Spaan J. A. E., Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy. American Journal of Physiology: Heart and Circulatory Physiology 2003 285 6 H2848 H2856 2-s2.0-0344872515 (Pubitemid 37443106)
120. Caro C. G., Fitz-Gerald J. M., Schroter R. C., Arterial wall shear and distribution of early atheroma in man. Nature 1969 223 5211 1159 1161 2-s2.0-0014673564 10.1038/2231159a0
121. Rubio-Gayosso I., Platts S. H., Duling B. R., Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury. American Journal of Physiology: Heart and Circulatory Physiology 2006 290 6 H2247 H2256 2-s2.0-33744924451 10.1152/ajpheart.00796.2005 (Pubitemid 43846051)
122. Bruegger D., Rehm M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Conzen P., Becker B. F., Exogenous nitric oxide requires an endothelial glycocalyx to prevent postischemic coronary vascular leak in guinea pig hearts. Critical Care 2008 12 3, article R73 2-s2.0-45749148221 10.1186/cc6913 (Pubitemid 351865983)
123. Bruegger D., Rehm M., Abicht J., Paul J. O., Stoeckelhuber M., Pfirrmann M., Reichart B., Becker B. F., Christ F., Shedding of the endothelial glycocalyx during cardiac surgery: on-pump versus off-pump coronary artery bypass graft surgery. Journal of Thoracic and Cardiovascular Surgery 2009 138 6 1445 1447 2-s2.0-71649084597 10.1016/j.jtcvs.2008.07.063
124. Rehm M., Bruegger D., Christ F., Conzen P., Thiel M., Jacob M., Chappell D., Stoeckelhuber M., Welsch U., Reichart B., Peter K., Becker B. F., Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia. Circulation 2007 116 17 1896 1906 2-s2.0-37349124206 10.1161/CIRCULATIONAHA.106.684852 (Pubitemid 350287085)
125. Schmidt E. P., Yang Y., Janssen W. J., The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nature Medicine 2012 18 1217 1223
126. Marechal X., Favory R., Joulin O., Montaigne D., Hassoun S., Decoster B., Zerimech F., Neviere R., Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008 29 5 572 576 2-s2.0-42149084524 10.1097/SHK.0b013e318157e926 (Pubitemid 351544076)
127. Hayashida K., Parks W. C., Pyong W. P., Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines. Blood 2009 114 14 3033 3043 2-s2.0-70449468813 10.1182/blood-2009- 02-204966
128. Donati A., Damiani E., Domizi R., Alteration of the sublingual microvascular glycocalyx in critically ill patients. Microvascular Research 2013 90 86 89
129. Sallisalmi M., Tenhunen J., Yang R., Oksala N., Pettilä V., Vascular adhesion protein-1 and syndecan-1 in septic shock. Acta Anaesthesiologica Scandinavica 2012 56 3 316 322 2-s2.0-84857239745 10.1111/j.1399-6576.2011. 02578.x
130. Steppan J., Hofer S., Funke B., Brenner T., Henrich M., Martin E., Weitz J., Hofmann U., Weigand M. A., Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. Journal of Surgical Research 2011 165 1 136 141 2-s2.0-78649947962 10.1016/j.jss.2009.04.034
131. Johansson P. I., Stensballe J., Rasmussen L. S., Ostrowski S. R., A high
132. Ostrowski S. R., Sorensen A. M., Windelov N. A., Perner A., Welling K.-L., Wanscher M., Larsen C. F., Johansson P. I., High levels of soluble VEGF receptor 1 early after trauma are associated with shock, sympathoadrenal activation, glycocalyx degradation and inflammation in severely injured patients: a prospective study. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2012 20, article 27 2-s2.0-84859497772 10.1186/1757-7241-20- 27
133. Hiebert L. M., Jaques L. B., The observation of heparin on endothelium after injection. Thrombosis Research 1976 8 2 195 204 2-s2.0-0017273853
134. Gambaro G., Venturini A. P., Noonan D. M., Fries W., Re G., Garbisa S., Milanesi C., Pesarini A., Borsatti A., Marchi E., Baggio B., Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney International 1994 46 3 797 806 2-s2.0-0028092966 (Pubitemid 24272038)
135. Achour A., Kacem M., Dibej K., Skhiri H., Bouraoui S., El May M., One year course of oral sulodexide in the management of diabetic nephropathy. Journal of Nephrology 2005 18 5 568 574 2-s2.0-29244469623 (Pubitemid 41824477)
136. Lauver D. A., Booth E. A., White A. J., Poradosu E., Lucchesi B. R., Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis. Journal of Pharmacology and Experimental Therapeutics 2005 312 2 794 800 2-s2.0-13244253793 10.1124/jpet.104.075283 (Pubitemid 40189581)
137. Myrup B., Yokoyama H., Kristiansen O. P., Østergaard P. B., Olivecrona T., Release of endothelium-associated protein into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes. Diabetic Medicine 2004 21 10 1135 1140 2-s2.0-6344253118 10.1111/j.1464-5491.2004.01313.x (Pubitemid 39389227)
138. Jacob M., Paul O., Mehringer L., Chappell D., Rehm M., Welsch U., Kaczmarek I., Conzen P., Becker B. F., Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009 87 7 956 965 2-s2.0-65549124024 10.1097/TP.0b013e31819c83b5
139. Jacob M., Bruegger D., Rehm M., Welsch U., Conzen P., Becker B. F., Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006 104 6 1223 1231 2-s2.0-33744960645 10.1097/00000542-200606000-00018 (Pubitemid 43852956)
140. Czarnowska E., Karwatowska-Prokopczuk E., Ultrastructural demonstration of endothelial glycocalyx disruption in the reperfused rat heart. Involvement of oxygen free radicals. Basic Research in Cardiology 1995 90 5 357 364 2-s2.0-0028806512 10.1007/BF00788496
141. Subramanian S. V., Fitzgerald M. L., Bernfield M., Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. The Journal of Biological Chemistry 1997 272 23 14713 14720 2-s2.0-0030967612 10.1074/jbc.272.23.14713 (Pubitemid 27251736)
142. Chappell D., Dörfler N., Jacob M., Rehm M., Welsch U., Conzen P., Becker B. F., Glycocalyx protection reduces leukocyte adhesion after ischemia/reperfusion. Shock 2010 34 2 133 139 2-s2.0-77954997615 10.1097/SHK.0b013e3181cdc363
143. Kilger E., Weis F., Briegel J., Frey L., Goetz A. E., Reuter D., Nagy A., Schuetz A., Lamm P., Knoll A., Peter K., Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery. Critical Care Medicine 2003 31 4 1068 1074 2-s2.0-0037387583 10.1097/01.CCM.0000059646.89546.98 (Pubitemid 36444415)
144. Chappell D., Heindl B., Jacob M., Annecke T., Chen C., Rehm M., Conzen P., Becker B. F., Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology 2011 115 3 483 491 2-s2.0-80052162260 10.1097/ALN.0b013e3182289988
145. Annecke T., Chappell D., Chen C., Jacob M., Welsch U., Sommerhoff C. P., Rehm M., Conzen P. F., Becker B. F., Sevoflurane preserves the endothelial glycocalyx against ischaemia-reperfusion injury. British Journal of Anaesthesia 2010 104 4 414 421 2-s2.0-77949395568 10.1093/bja/aeq019
146. Annecke T., Rehm M., Bruegger D., Ischemia-reperfusion-induced unmeasured anion generation and glycocalyx shedding: sevoflurane versus propofol anesthesia. Journal of Investigative Surgery 2012 25 3 162 168 10.3109/08941939.2011.618524
147. Wacker J., Lucchinetti E., Jamnicki M., Aguirre J., Härter L., Keel M., Zaugg M., Delayed inhibition of agonist-induced granulocyte-platelet aggregation after low-dose sevoflurane inhalation in humans. Anesthesia and Analgesia 2008 106 6 1749 1758 2-s2.0-44649186880 10.1213/ane.0b013e318172f9e9
148. Lucchinetti E., Aguirre J., Feng J., Zhu M., Suter M., Spahn D. R., Härter L., Zaugg M., Molecular evidence of late preconditioning after sevoflurane inhalation in healthy volunteers. Anesthesia and Analgesia 2007 105 3 629 640 2-s2.0-34548129629 10.1213/01.ane.0000278159.88636.aa (Pubitemid 47300836)
149. Lucchinetti E., Ambrosio S., Aguirre J., Herrmann P., Härter L., Keel M., Meier T., Zaugg M., Sevoflurane inhalation at sedative concentrations provides endothelial protection against ischemia-reperfusion injury in humans. Anesthesiology 2007 106 2 262 268 2-s2.0-33846648714 10.1097/00000542-200702000- 00013 (Pubitemid 46185170)
150. De Klaver M. J. M., Buckingham M.-G., Rich G. F., Isoflurane pretreatment has immediate and delayed protective effects against cytokine-induced injury in endothelial and vascular smooth muscle cells. Anesthesiology 2003 99 4 896 903 2-s2.0-0141655162 10.1097/00000542-200310000-00023 (Pubitemid 37186081)
151. Meuwese M. C., Mooij H. L., Nieuwdorp M., van Lith B., Marck R., Vink H., Kastelein J. J. P., Stroes E. S. G., Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia. Journal of Lipid Research 2009 50 1 148 153 2-s2.0-63449141759 10.1194/jlr.P800025-JLR200